会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • ELECTROCHEMICAL BLOOD MIMICKING FLUID
    • 电化学血液模拟液
    • WO2017108765A1
    • 2017-06-29
    • PCT/EP2016/081890
    • 2016-12-20
    • CILAG GMBH INTERNATIONAL
    • MACFIE, Gavin
    • C12Q1/00G01N27/327
    • C12Q1/006G01N27/3274G01N33/96G01N2496/10
    • A fluid mimicking electrochemical properties of blood includes a base fluid and particles dispersed in the base fluid. The fluid has rheological properties that mimic blood, and the dispersion of the particles may be maintained for a range of hematocrit equivalent levels. In addition, a method for preparing a blood mimicking fluid for use with an electrochemical biosensor includes dispersing particles into a base fluid, and introducing an analyte that is compatible with the electrochemical biosensor into the base fluid. Further, a method of testing an electrochemical biosensor includes the steps of obtaining a blood mimicking fluid having a predetermined concentration of the analyte and having rheological and electrochemical properties in combination mimicking blood, assaying the blood mimicking fluid to measure an analyte concentration, and comparing the measured analyte concentration and the predetermined analyte concentration.
    • 模拟血液电化学特性的流体包括基液和分散在基液中的颗粒。 该流体具有模拟血液的流变性质,并且可以保持一定范围的血细胞比容等效水平的颗粒分散。 另外,用于制备供电化学生物传感器使用的血液模拟流体的方法包括将颗粒分散到基础流体中,并将​​与电化学生物传感器相容的分析物引入到基础流体中。 此外,测试电化学生物传感器的方法包括以下步骤:获得具有预定浓度的分析物并且具有模拟血液的流变学和电化学性质的血液模拟流体,分析血液模拟流体以测量分析物浓度,以及比较 测量的分析物浓度和预定的分析物浓度。
    • 5. 发明申请
    • QUALITY CONTROL METHOD OF HEMATOLOGY INSTRUMENTS
    • HEMATOLOGY仪器质量控制方法
    • WO1996034291A1
    • 1996-10-31
    • PCT/US1996005941
    • 1996-04-29
    • COULTER INTERNATIONAL CORP.
    • COULTER INTERNATIONAL CORP.YOUNG, Carole
    • G01N33/96
    • G01N33/96G01N15/1012G01N15/12G01N33/5094G01N33/92G01N2496/05G01N2496/10
    • A method of quality control to diagnose the cause of a malfunction of an instrument. The method uses measurements of the physical property of a sample to diagnose the cause of a malfunction of an instrument. The spatial position of a control product sample is analysed. Alternatively, the spatial position of a statistically significant number of patient blood samples can be used. The method enables the monitoring of an instrument for problems associated with debris and noise caused by red cell lysis inefficiency; instrument reagents pump volume settings; instrument laser alignments; instrument gain settings; and flow noise caused by partial plugs, residual plugs or other flow problems. The method provides a more specific indication of the type and cause of an instrument malfunctioning than non specific flagging is provided by prior art methods.
    • 一种用于诊断仪器故障原因的质量控制方法。 该方法使用样品的物理性质的测量来诊断仪器故障的原因。 分析对照产品样品的空间位置。 或者,可以使用统计学上显着数量的患者血液样本的空间位置。 该方法能够监测仪器与由红细胞裂解无效率引起的碎片和噪声相关的问题; 仪器试剂泵体积设置; 仪器激光对准 仪器增益设置; 和由部分插头,残留插头或其他流量问题引起的流动噪声。 该方法提供了比现有技术方法提供的非特定标记的仪器故障的类型和原因的更具体的指示。
    • 7. 发明申请
    • HEMATOLOGY LINEARITY CONTROL COMPOSITION SYSTEM AND METHOD OF USE
    • 血液学线性控制组合物系统及其使用方法
    • WO2008061073A2
    • 2008-05-22
    • PCT/US2007084477
    • 2007-11-13
    • BECKMAN COULTER INC
    • ORTIZ NERYGERULA THEODORE J
    • G01N33/48G01N37/00
    • G01N33/96G01N15/12G01N2015/1006G01N2496/10Y10T436/10Y10T436/101666
    • A linearity control system includes a series of linearity control compositions, each thereof includes white blood cell analogs and stabilized red blood cells in a suspension medium. The concentration of the white blood cell analogs in the series of control compositions increases from 0.2 x 10 3 to 800 x 10 3 analogs per microliter, and the concentration of the white blood cell analogs in at least one control composition is greater than 120 x 10 3 analogs per microliter. The stabilized red blood cells facilitate mono-dispersion of the white blood cell analogs in the suspension medium by gently mixing. The control compositions further include platelet analogs, or additionally include reticulocyte and/or nucleated red blood cell analogs. The linearity control system allows the verification of the reportable measurement range and linearity of the measurements of hematology analyzers for white blood cells, red blood cells and platelets in extended concentration ranges.
    • 线性控制系统包括一系列线性控制组合物,其中每一个包括悬浮介质中的白细胞类似物和稳定的红细胞。 一系列对照组合物中白细胞类似物的浓度从每微升升高0.2×10 3至800×10 3个类似物,并且白血浓度 至少一种对照组合物中的细胞类似物的每微升大于120×10 3个类似物。 稳定的红细胞促进白细胞类似物在悬浮介质中的单分散,通过轻轻混合。 对照组合物还包括血小板类似物,或另外包括网织红细胞和/或有核红细胞类似物。 线性控制系统允许验证可扩展浓度范围内白细胞,红细胞和血小板的血液分析仪的可报告测量范围和线性度。